Opportunities to expand delivery of prehospital tranexamic acid to bleeding trauma patients – findings from a prospective multicentre trauma study in the Western Cape Province, South Africa
DOI:
https://doi.org/10.7196/Keywords:
Tranexamic Acid , Wounds and Injury , Haemorrhage, Emergency Medical ServicesAbstract
Background. Traumatic haemorrhage is a leading cause of preventable injury-related deaths. Tranexamic acid (TXA) has demonstrated a 38% all-cause mortality reduction when administered to severe haemorrhagic shock patients in South Africa (SA). Yet its prehospital utilisation in SA remains limited owing to prehospital provider qualification restrictions, despite the region’s high trauma burden. Among the 4% of prehospital providers licensed to administer TXA, prehospital eligibility and TXA administration is poorly reported. This utilisation gap suggests multifactorial barriers beyond the current scope of practice restrictions that impede effective implementation of this evidence-based intervention.
Objective. To assess patterns of TXA administration and omission during prehospital emergency care in the Western Cape Province, SA.
Methods. This is a secondary analysis from the EpiC prospective multicentre study. The current study examined 4 094 patients at risk of haemorrhage in the Western Cape from August 2021 to December 2024. First, we assessed patient and injury characteristics as well as prehospital and hospital treatments among three prehospital treatment groups: those who received TXA; those who received a lifesaving circulation intervention and no TXA; and those who received neither. Second, a subset of patients was selected for three clinical scenarios: patients with moderate to severe risk of shock; those with severe shock meeting TXA eligibility criteria; and those requiring hospital-based interventions for haemorrhage. Prehospital provider qualifications, clinical interventions and outcomes were assessed using descriptive statistics, and Sankey diagrams were used to visually depict the quantity and flow of prehospital trauma patients stratified by prehospital provider qualification.
Results. Only 2.8% (n=116) of all haemorrhage-risk patients received prehospital TXA despite 82% (n=3 325) presenting within the 3-hour window for administration. Among eligible patients with severe risk of shock who were managed by an advanced prehospital provider (n=161), only 19% (n=30) received TXA. Basic and intermediate prehospital providers, who cannot administer TXA under current regulations, managed 67% (n=326) of these patients. These providers frequently delivered other life-saving circulatory interventions (70 - 79%).
Conclusion. This study reveals that only a small percentage of eligible trauma patients receive TXA despite its established mortality benefit. The principal barrier identified is the current scope-of-practice restriction preventing basic and intermediate prehospital providers from administering TXA, despite managing two-thirds of eligible patients and possessing the knowledge and skills to deliver TXA. We strongly recommend that the scope of TXA be extended to intermediate prehospital providers in SA.
References
1. World Health Organization. Injuries and violence. Geneva: WHO, 2024. https://www.who.int/news- room/fact-sheets/detail/injuries-and-violence (accessed 27 February 2025).
2. National Safety Council. Injury facts: International overview. Itasca: NSC, 2022. https://injuryfacts.nsc. org/international/international-overview/ (accessed 27 February 2025).
3. Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990 - 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396(10258):1204-1222. https://doi.org/10.1016/s0140-6736(20)30925-9
4. Haagsma JA, Graetz N, Bolliger I, et al. The global burden of injury: Incidence, mortality, disability- adjusted life years and time trends from the Global Burden of Disease study 2013. Injury Prev 2016;22(1):3-18. https://doi.org/10.1136/injuryprev-2015-041616
5. Gosselin R. Injuries: The neglected burden in developing countries. Bull World Health Org 2009;87(4):246-246. https://doi.org/10.2471/blt.08.052290
6. Mock CN, Jurkovich GJ, nii-Amon-Kotei D, Arreola-Risa C, Maier RV. Trauma mortality patterns in three nations at different economic levels. J Trauma Acute Care Surg 1998;44(5):804-814. https://doi. org/10.1097/00005373-199805000-00011
7. Jones AR, Miller J, Brown M. Epidemiology of trauma-related hemorrhage and time to definitive care across North America: Making the case for bleeding control education. Prehospital Disaster Med 2023;38(6):780. https://doi.org/10.1017/S1049023X23006428
8. Mould-Millman NK, Sasser S, Wallis L. Prehospital research in sub-Saharan Africa: Establishing research tenets. Acad Emerg Med 2013;20:1304-1309. https://doi.org/10.1111/acem.12269
9. Bedard AF, Mata LV, Dymond C, et al. A scoping review of worldwide studies evaluating the effects of prehospital time on trauma outcomes. Int J Emerg Med 2020;13(1):64. https://doi.org/10.1186/s12245- 020-00324-7
10. Suryanto S, Plummer V, Boyle M. EMS systems in lower-middle income countries: A literature review. Prehospital Disaster Med 2016,32(1):64-70. https://doi.org/10.1017/S1049023X1600114X
11. Kironji AG, Hodkinson P, de Ramirez SS, et al. Identifying barriers for out of hospital emergency care in low and low-middle income countries: A systematic review. BMC Health Serv Res 2018;18(1):291. https://doi.org/10.1186/s12913-018-3091-0
12. Mould-Millman NK, Dixon JM, Sefa N, et al. The state of emergency medical services (EMS) systems in Africa. Prehospital Disaster Med 2017;32(3):273-283. https://doi.org/10.1017/S1049023X17000061
13. Matzopoulos R, Prinsloo M, Pillay-van Wyk V, et al. Injury-related mortality in South Africa: A retrospective descriptive study of postmortem investigations. Bull World Health Org 2015;93(5):303-
313. https://doi.org/10.2471/BLT.14.145771
14. Groenewald P, Neethling I, Evans J, et al. Mortality trends in the City of Cape Town between 2001
and 2013: Reducing inequities in health. S Afr Med J 2017;107(12):1091-1098. https://doi.org/10.7196/
SAMJ.2017.v107i12.12458
15. Hardcastle TC, Clarke D, Oosthuizen G, Lutge E. Trauma, a preventable burden of disease in South Africa: Review of the evidence, with a focus on KwaZulu-Natal. S Afr Health Rev 2016;2016(1):179- 189.
16. Abdullah N, Saunders C, McCaul M, Nyasulu P. A retrospective study of the pre-hospital trauma burden managed by the Western Cape Government Emergency Medical Services. S Afr J Pre Hosp Emerg Care 2021;2(1):18-26. https://doi.org/10.24213/2-1-4440
17. Tisherman SA, Schmicker RH, Brasel KJ, et al. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the resuscitation outcomes consortium. Ann Surg 2015;261(3):586. https://doi.org/10.1097/SLA.0000000000000837
18. Moresky RT, Razzak J, Reynolds T, et al. Advancing research on emergency care systems in low- income and middle-income countries: Ensuring high-quality care delivery systems. BMJ Glob Health 2019;4(Suppl 6):e001265. https://doi.org/10.1136/bmjgh-2018-001265
19. Kalkwarf KJ, Drake SA, Yang Y, et al. Bleeding to death in a big city: An analysis of all trauma deaths from hemorrhage in a metropolitan area during 1 year. J Trauma Acute Care Surg 2020;89(4):716-722. https://doi.org/10.1097/TA.0000000000002833
20. Smith AA, Ochoa JE, Wong S, et al. Prehospital tourniquet use in penetrating extremity trauma: Decreased blood transfusions and limb complications. J Trauma Acute Care Surg 2019;86(1):43. https://doi.org/10.1097/TA.0000000000002095
21. Drake SA, Holcomb JB, Yang Y, et al. Establishing a regional trauma preventable/potentially preventable death rate. Ann Surg 2020;271(2):375-382. https://doi.org/10.1097/SLA.0000000000002999
22. Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: A randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess 2013;17(10):1-79. https://doi. org/10.3310/hta17100
23. Acharya P, Amin A, Nallamotu S, et al. Prehospital tranexamic acid in trauma patients: A systematic review and meta-analysis of randomised controlled trials. Front Med 2023;20(10):1284016. https://doi. org/10.3389/fmed.2023.1284016
24. Fouche PF, Stein C, Nichols M, et al. Tranexamic acid for traumatic injury in the emergency setting: A systematic review and bias-adjusted meta-analysis of randomised controlled trials. Ann Emerg Med 2024;83(5):435-445. https://doi.org/10.1016/j.annemergmed.2023.10.004
25. Alhenaki AM, Ali AS, Kadir B, Ahmed Z. Pre-hospital administration of tranexamic acid in trauma patients: A systematic review and meta-analysis. Trauma 2022;24(3):185-194. https://doi. org/10.1177/14604086211001163
26. Guyette FX, Brown JB, Zenati MS, et al. Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: A double-blind, placebo-controlled, randomised clinical trial. JAMA Surg 2020;156(1):11-20. https://doi.org/10.1001/jamasurg.2020.4350
27. The PATCH-Trauma Investigators, ANZICS Clinical Trials Group. Prehospital tranexamic acid for severe trauma. N Engl J Med 2023;389(2):127-136. https://doi.org/10.1056/NEJMoa2215457
28. Wogu AF, Dixon JM, Xiao M, et al. Tranexamic acid is associated with post-injury mortality in a resource-limited trauma system: Findings from the epidemiology and outcomes of prolonged trauma care cohort study. Transfusion 2025;65(S1):S276-S287. https://doi.org/10.1111/trf.18171
29. Sobuwa S, Christopher L. Emergency care education in South Africa: Past, present and future. Australas J Paramed 2019;16:01-5. https://doi.org/10.33151/ajp.16.647
30. Tiwari R, Naidoo R, English R, Chikte U. Estimating the emergency care workforce in South Africa. Afr J Prim Health Care Fam Med 2021;13(1):9. https://doi.org/10.4102/phcfm.v13i1.3174
31. Health Professions Council of South Africa. Clinical practice guidelines. Pretoria: HPCSA, 2019. https://hpcsa.co.za/c9d35f68-f0de-4082-b50f-187302c96603 (accessed 26 September 2024).
32. Al-Jeabory M, Szarpak L, Attila K, et al. Efficacy and safety of tranexamic acid in emergency trauma: A systematic review and meta-analysis. J Clin Med 2021;10(5):1030. https://doi.org/10.3390/ jcm10051030
33. Chen HY, Wu LG, Fan CC, Yuan W, Xu WT. Effectiveness and safety of prehospital tranexamic acid in patients with trauma: An updated systematic review and meta-analysis with trial sequential analysis. BMC Emerg Med 2024;24(1):202. https://doi.org/10.1186/s12873-024-01119-2
34. Setliff J, Dalton J, Sadhwani S, et al. Examining the safety profile of a standard dose tranexamic acid regimen in spine surgery. Neurosurg Focus 2023;55(4):E16. https://doi. org/10.3171/2023.7.FOCUS23384
35. Suresh K, Dixon JM, Patel C, et al. The epidemiology and outcomes of prolonged trauma care (EpiC) study: Methodology of a prospective multicenter observational study in the Western Cape of South Africa. Scand J Trauma Resusc Emerg Med 2022;30(1):55. https://doi.org/10.1186/s13049-022-01041-1
36. Mould-Millman NK, Dixon JM, van Ster B, et al. Clinical impact of a prehospital trauma shock bundle of care in South Africa. Afr J Emerg Med 2022;12(1):19-26. https://doi.org/10.1016/j.afjem.2021.10.003 37. Drew B, Auten JD, Cap AP, et al. The use of tranexamic acid in tactical combat casualty care: TCCC
proposed change 20-02. J Spec Oper Med 2020;20(3):36. https://doi.org/10.55460/ZWV3-5CBW
38. Gunn F, Stevenson R, Almuwallad A, et al. A comparative analysis of tranexamic acid dosing strategies in traumatic major hemorrhage. J Trauma Acute Care Surg 2024;96(2):216-224. https://doi.
org/10.1097/TA.0000000000004177
39. Steele D, Ballard PK, Burke R, Ferguson B. Intramuscular tranexamic acid administration on the battlefield. Case Rep Emerg Med 2022;2022:9689923. https://doi.org/10.1155/2022/9689923
40. Utsumi S, Kawakami A, Amemiya Y. Optimal dose of tranexamic acid in traumatic brain injury: Systematic review and network meta-analysis of randomised controlled trials. J Trauma Acute Care Surg 2025;98(5):816-823. https://doi.org/10.1097/TA.0000000000004500
41. Vu EN, Wan WCY, Yeung TC, Callaway DW. Intramuscular tranexamic acid in tactical and combat settings. J Spec Oper Med 2018;18(1):62-68. https://doi.org/10.55460/plw2-kn9z
42. Brenner A, Shakur-Still H, Chaudhri R, et al. Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: A randomised placebo-controlled trial (I’M WOMAN). Trials 2023;24(1):782. https://doi.org/10.1186/s13063-023- 07687-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 N Abdullah, J Young, W Stassen, C Wylie, H J Lategan, G Oosthuizen, S de Vries, J Verster, EpiC Study Site Collaborators, J M Dixon, N-K Mould-Millman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
